Our results reveal that LRRK2-I1371V induces glucose uptake deficits, leading to energy depletion and integrated ER-mitochondria-lysosome dysfunction, thus indicating restoration of astrocytic metabolic capacity as a potential therapeutic strategy for LRRK2-associated PD. This evidence concerns the gene LRRK2 and Parkinson disease.